Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nikhil Mehta

Diagnostic Radiology Scottsdale, AZ Medical Doctor

NPI 1275761595 CMS profile 1302792

22455 N Miller Rd Ste B100, Scottsdale, AZ 85255

Open in the dashboard

General payments

$27,631

160 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nikhil Mehta of Scottsdale, AZ is reported in the CMS Open Payments database as having received $27,631 across 160 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,206 37
2024 General $5,028 29
2023 General $3,239 31
2022 General $3,333 27
2021 General $2,823 13
2020 General $1,536 11
2019 General $465 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nikhil Mehta
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Nikhil Mehta were reported at $11,206. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Nikhil Mehta Diagnostic Radiology median Middle half National median
2019 $465 $108 $29–$318 $163
2020 $1,536 $65 $21–$252 $114
2021 $2,823 $92 $24–$292 $132
2022 $3,333 $104 $29–$294 $149
2023 $3,239 $110 $29–$337 $160
2024 $5,028 $113 $30–$356 $164
2025 $11,206 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $10,898 26 payments
  2. Penumbra, Inc. $7,280 22 payments
  3. Sirtex Medical Inc $3,931 10 payments
  4. Imperative Care, INc $1,384 21 payments
  5. Boston Scientific Corporation $799 18 payments
  6. Medtronic USA, Inc. $521 12 payments
  7. Inari Medical, Inc. $472 4 payments
  8. Route 92 Medical, Inc. $447 3 payments
  9. Stryker Corporation $289 9 payments
  10. InspireMD Ltd $206 5 payments
  11. Other $1,403 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,000 6 payments
  2. Food and Beverage $7,888 142 payments
  3. Travel and Lodging $4,608 11 payments
  4. Education $136 1 payment
Products named General payments · program years 2019–2025
  1. WEB ANEURYSM EMBOLIZATION SYSTEM $9,987 21 payments
  2. Smart Coil $4,764 6 payments
  3. SIR-Spheres Microspheres $3,800 9 payments
  4. Benchmark $1,323 2 payments
  5. ZOOM 88-T LARGE DISTAL PLATFORM $1,086 11 payments
  6. WEB $891 3 payments
  7. CT THROMBECTOMY SYSTEM KIT $520 7 payments
  8. FLOWTRIEVER CATHETER, S $520 7 payments
  9. RED 72 $357 5 payments
  10. Penumbra System $317 4 payments
  11. Other $5,023 135 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 74 billing codes

Paid by Medicare

$163,154

Of which drugs: $114

Medicare patients

154

Average age 75

Services billed

1,863

87 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Ischemic heart disease 39%
Atrial fibrillation 38%
Chronic kidney disease 35%
Diabetes 29%
Heart failure 25%
Depression 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 14 1,190 $114

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

160 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record